Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 16.241% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a) Cn1c(=O)c2[nH]c(N3CCOCC3)nc2n(-c2ccccc2)c1=O
b) Cl.NC(N)=NC(=O)c1nc(Cl)c(N)nc1N.O
c) COc1ccccc1Oc1ccc2c(c1)C(=O)N(c1cccc(O)c1)C2=O
d) CCCCN(C)C(=O)CCC(=O)Nc1ccc2nc(N3CCOCC3)cc(C)c2c1
e) CC(C)CCNc1nc(N)c([N+](=O)[O-])c(NC2CCCCC2)n1
Answer: e. CC(C)CCNc1nc(N)c([N+](=O)[O-])c(NC2CCCCC2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)CCNc1nc(N)c([N+](=O)[O-])c(NC2CCCCC2)n1
CC(C)CCNc1nc(N)c([N+](=O)[O-])c(NC2CCCCC2)n1
4-N-cyclohexyl-2-N-(3-methylbutyl)-5-nitropyrimidine-2,4,6-triamine